Key facts
- This page summarizes Christopher Peetz's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2024, 17:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
Additional SEC filing notes
Footnote F1
Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units.
Footnote F2
7,000 shares held indirectly by the reporting person were inadvertently reported on prior Form 4 filings as direct holdings. The reporting person's holdings on this Form 4 have been adjusted accordingly.